Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations

被引:397
作者
Jankovic, J
机构
[1] Baylor Coll Med, Parkinsons Dis Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Movement Disorders Clin, Dept Neurol, Houston, TX 77030 USA
关键词
motor complications; Parkinson's disease; dyskinesia; wearing off; levodopa;
D O I
10.1002/mds.20458
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Fluctuations in the symptoms of Parkinson's disease (PD), such as wearing-off and on-off effects, and dyskinesias are related to a variety of factors, including duration and dosage of levodopa, age at onset, stress, sleep, food intake, and other pharmacokinetic and pharmacodynamic mechanisms. The majority of patients, particularly those with young onset of PD, experience these levodopa-related adverse effects after a few years of treatment. Assessment of these motor complications is difficult because of the marked clinical variability between and within patients. Daily diaries have been used in clinical trials designed to assess the effects of various pharmacological and surgical interventions on motor fluctuations and dyskinesias. The most common type of dyskinesia, called "peak-dose dyskinesia", usually consists of stereotypical choreic or ballistic movements involving the head, trunk, and limbs, and occasionally, the respiratory muscles, whereas tremor and punding are less-common complications. Dystonia is also typically seen in patients with diphasic dyskinesia and wearing-off effect. Recognition of the full spectrum of clinical phenomenology of levodopa-related motor complications is essential for their treatment and prevention. (c) 2005 Movement Disorder Society.
引用
收藏
页码:S11 / S16
页数:6
相关论文
共 69 条
[31]   Health related quality of life in Parkinson's disease:: a prospective longitudinal study [J].
Karlsen, KH ;
Tandberg, E ;
Årsland, D ;
Larsen, JP .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (05) :584-589
[32]   Parkin disease: a phenotypic study of a large case series [J].
Khan, NL ;
Graham, E ;
Critchley, P ;
Schrag, AE ;
Wood, NW ;
Lees, AJ ;
Bhatia, KP ;
Quinn, N .
BRAIN, 2003, 126 :1279-1292
[33]   Ten-year follow-up of three different initial treatments in de-novo PD - A randomized trial [J].
Lees, AJ ;
Katzenschlager, R ;
Head, J ;
Ben-Shlomo, Y .
NEUROLOGY, 2001, 57 (09) :1687-1694
[34]   Dyskinesia after fetal cell transplantation for parkinsonism: A PET study [J].
Ma, YL ;
Feigin, A ;
Dhawan, V ;
Fukuda, M ;
Shi, QH ;
Greene, P ;
Breeze, R ;
Fahn, S ;
Freed, C ;
Eidelberg, D .
ANNALS OF NEUROLOGY, 2002, 52 (05) :628-634
[35]   An ambulatory dyskinesia monitor [J].
Manson, AJ ;
Brown, P ;
O'Sullivan, JD ;
Asselman, P ;
Buckwell, D ;
Lees, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (02) :196-201
[36]   LEVODOPA-INDUCED DYSKINESIAS IN PARKINSONS-DISEASE PHENOMENOLOGY AND PATHOPHYSIOLOGY [J].
MARCONI, R ;
LEFEBVRECAPARROS, D ;
BONNET, AM ;
VIDAILHET, M ;
DUBOIS, B ;
AGID, Y .
MOVEMENT DISORDERS, 1994, 9 (01) :2-12
[37]   Measuring motor complications in clinical trials for early Parkinson's disease [J].
Marras, C ;
Lang, AE .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (02) :143-146
[38]   Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations [J].
Marras, C ;
Lang, A ;
Krahn, M ;
Tomlinson, G ;
Naglie, G .
MOVEMENT DISORDERS, 2004, 19 (01) :22-28
[39]  
Metman LV, 2000, MOVEMENT DISORD, V15, P3, DOI 10.1002/1531-8257(200001)15:1<3::AID-MDS1003>3.0.CO
[40]  
2-E